A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2002
12/19/2002	WO2002100438A1 Oral controlled release drug delivery system with husk powder from lepidium sativum seeds
12/19/2002	WO2002100437A2 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	WO2002100436A2 Ophthalmic once-a-day composition
12/19/2002	WO2002100425A1 Aggregate composition for sustained-release preparation, process for producing the same, and sustained-release preparation containing the same
12/19/2002	WO2002100422A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
12/19/2002	WO2002100420A2 Pharmaceutical zeolite-based compositions containing zinc and erythromycin, to be used in the treatment of acne
12/19/2002	WO2002100418A1 Exothermic formulations for the treatment of ectoparasites
12/19/2002	WO2002100412A2 Stabilized dispersion of phytosterol in oil
12/19/2002	WO2002100407A1 Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
12/19/2002	WO2002100395A1 Bismuth salts of anti-oxidants and radical scavengers for prevention and treatment of mucous membrane ulcers
12/19/2002	WO2002100394A1 Oral pharmaceutical composition containing a statin derivative
12/19/2002	WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	WO2002100391A1 Swallow tablet comprising paracetamol
12/19/2002	WO2002100389A2 Compressible guaifenesin compositions and method for producing them
12/19/2002	WO2002100386A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
12/19/2002	WO2002100385A1 Crude drug patch
12/19/2002	WO2002100384A1 Sheet-like patch agent
12/19/2002	WO2002100382A2 Controlled release dosage forms using acrylic polymer, and process for making the same
12/19/2002	WO2002100381A1 Functional grain-containing preparations quickly disintegrated in the oral cavity
12/19/2002	WO2002100380A1 Production of hard, dense particles
12/19/2002	WO2002100379A1 Method for preparing solid dispersion
12/19/2002	WO2002100378A2 Process for the preparation of a particulate material
12/19/2002	WO2002100377A1 PHARMACEUTICAL FORMULATION FOR THE EFFICIENT ADMINISTRATION OF APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND THEIR DERIVATIVES AND PRO-DRUGS THEREOF
12/19/2002	WO2002100376A1 Ophthalmic compositions comprising chitosan and an active substance, in particular ketotifen, and use thereof for the treatment of ocular allergic conditions
12/19/2002	WO2002100370A1 Breath protection microcapsules
12/19/2002	WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof
12/19/2002	WO2002100346A2 (r, r'),(r',s')-amphetaminil, compositions and uses thereof
12/19/2002	WO2002100343A2 N-terminally truncated galectin-3 and antibodies for treating cancer
12/19/2002	WO2002100342A2 (s, s'), (s, r')-amphetaminil, compositions and uses thereof
12/19/2002	WO2002100338A2 Compound and composition for delivering active agents
12/19/2002	WO2002100325A2 Polyvalent nanoparticles
12/19/2002	WO2002100319A2 Method for cleaning hard gelatine capsules
12/19/2002	WO2002100309A1 Quinolone carboxylic acid compositions and related methods of treatment
12/19/2002	WO2002100172A1 Administration of agents via the pept-2 transporter
12/19/2002	WO2002085327A3 Use of nsaids for prevention and treatment of cellular abnormalities of the female reproductive tract
12/19/2002	WO2002080981A3 Polynucleotide binding complexes comprising sterols and saponins
12/19/2002	WO2002076514A3 Use of solid particles for thermally extracting perfume oils and/or aromas
12/19/2002	WO2002067894A3 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
12/19/2002	WO2002066012A3 Amphoteric liposomes and the use thereof
12/19/2002	WO2002065981A3 Chemotherapeutic composition using calcium phosphate paste
12/19/2002	WO2002060421A3 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence
12/19/2002	WO2002058705A3 Degradation-resistant glucocorticosteroid formulations
12/19/2002	WO2002058672A3 Microparticles of biodegradable polymer encapsulating a biologically active substance
12/19/2002	WO2002056878A3 Pharmaceutical composition having reduced tendency for drug crystallization
12/19/2002	WO2002043706A9 Prolamin-based sustained-release compositions and delayed-onset compositions
12/19/2002	WO2002032395A3 Sustained release delivery system and uses thereof
12/19/2002	WO2002028887A3 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
12/19/2002	WO2002026210A3 Proton pump inhibitor formulation
12/19/2002	WO2001087301A9 Methods for treatment of inflammatory diseases
12/19/2002	WO2001070032A9 Recombinant parainfluenza virus expression systems and vaccines
12/19/2002	US20020193758 Product
12/19/2002	US20020193730 Intrapulmonary delivery of polypeptide growth factors and cytokines
12/19/2002	US20020193729 Microprojection array immunization patch and method
12/19/2002	US20020193576 Mixture for use in the prevention and treatmenyt of infection
12/19/2002	US20020193544 Water-soluble or water-swellable crosslinked copolymers
12/19/2002	US20020193452 Conveying the biopolymeric substance used to manufacture capsules
12/19/2002	US20020193445 Controlled release for fast peak plasma concentration of the active metabolite desglymidodrine; treating orthostaic hypotension and/or urinary incontinence
12/19/2002	US20020193442 Method and compositions for the treatment or amelioration of female sexual dysfunction
12/19/2002	US20020193440 Liothyronine sodium and levothyroxine sodium combination
12/19/2002	US20020193438 Aripiprazole oral solution
12/19/2002	US20020193417 A liquid nasal pharmaceutical formulation consists of one or more active substances suitable for nasal administration, sorbitol, a water soluble c1-c4-allkylcelluose derivatives, a vehicle such as water,propylene glycol, and glycerol
12/19/2002	US20020193406 Novel compound
12/19/2002	US20020193397 Nasal delivery of apomorphine
12/19/2002	US20020193392 For therpay of respiratory disease is asthma or chronic obstructive pulmonary disease
12/19/2002	US20020193391 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
12/19/2002	US20020193370 For therapy and prophylaxis of ophthalmic, otic or nasal infections and attendant inflammation
12/19/2002	US20020193355 For therapy and prophylaxis of osteoporosis
12/19/2002	US20020193349 For use in formulation for oral cavity, cosmetics
12/19/2002	US20020193342 Modifying undesirable tastes
12/19/2002	US20020193338 Applying a biocompatible matrix containing the DNA molecule to a wound in the body, so that repair cells that migrate to the wound site infiltrate the matrix, acquire the DNA molecule, and express the gene product encoded by the DNA in vivo
12/19/2002	US20020193331 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications
12/19/2002	US20020193322 Adding trisubstituted salt of glycyrrhizic acid to aqueous soltuion of first physiologically acceptable compound of an acidic nature, and second physiologically acceptable compound of a basic nature
12/19/2002	US20020193321 Shelf life
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193290 Methods for fine powder formation
12/19/2002	US20020193026 When warmed, it can evolve steam that results from water in the gel; it can be used to give moisutre to and warm up human body, or to cool down it; is useful to promote percutaneous or endermic absorption of the medicines and cosmetics
12/19/2002	US20020192814 Colloidal metal compositions and methods
12/19/2002	US20020192794 Purification of plasmin; obtain sample of plasminogen, incubate with activator, recover plasmin
12/19/2002	US20020192651 Method of preventing aggregation of a lipid: nucleic acid complex
12/19/2002	US20020192354 Calorically dense liquid oral supplement
12/19/2002	US20020192316 Novel chocolate composition as delivery system for nutrients and medications
12/19/2002	US20020192307 Method and composition for enhancing sexual desire
12/19/2002	US20020192304 Pharmaceutical composition and method for relieving itch, pain and swelling resulting from insect bites and stings
12/19/2002	US20020192302 Transdermal and topical administration of antidepressant drugs using basic enhancers
12/19/2002	US20020192301 Transdermal and topical administration of antihypertensive agents using basic enhancers
12/19/2002	US20020192300 Transdermal and topical administration of antipsychotic agents using basic enhancers
12/19/2002	US20020192299 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
12/19/2002	US20020192298 Treatment of acne
12/19/2002	US20020192297 Hydrogen peroxide disinfectant with increased activity
12/19/2002	US20020192294 Induced phase transition method for the production of microparticles containing hydrophobic active agents
12/19/2002	US20020192293 Method for manufacture of extended release dosage form
12/19/2002	US20020192292 Microparticulate form of a tetrahydropyridin derivative
12/19/2002	US20020192291 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems
12/19/2002	US20020192290 Composition with sustained release of levodopa and carbidopa
12/19/2002	US20020192288 Methods and compositions for treating pain of the mucous membrane
12/19/2002	US20020192287 Extrudable compositions for topical or transdermal drug delivery
12/19/2002	US20020192286 Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
12/19/2002	US20020192285 Controlled release pellet formulation
12/19/2002	US20020192284 Tablet coating composition
12/19/2002	US20020192283 Odor-masking coating for a pharmaceutical preparation

1 ... 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 ... 2991